Pseudomonas Stutzeri InfectionsSymptoms, Doctors, Treatments, Advances & More
Pseudomonas Stutzeri Infections Overview
Learn About Pseudomonas Stutzeri Infections
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Felix Ratjen practices practicing medicine in Toronto, Canada. Mr. Ratjen is rated as an Elite expert by MediFind in the treatment of Pseudomonas Stutzeri Infections. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Cystic Fibrosis, Pseudomonas Stutzeri Infections, Hereditary Hemorrhagic Telangiectasia, Lung Transplant, and Liver Embolization.
Susanne Haussler practices practicing medicine in Hannover, Germany. Ms. Haussler is rated as an Elite expert by MediFind in the treatment of Pseudomonas Stutzeri Infections. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Pseudomonas Stutzeri Infections, Cystic Fibrosis, Salmonella Enterocolitis, and Hospital-Acquired Pneumonia.
Michael Parkins practices practicing medicine in Calgary, Canada. Mr. Parkins is rated as an Elite expert by MediFind in the treatment of Pseudomonas Stutzeri Infections. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Cystic Fibrosis, Pseudomonas Stutzeri Infections, Pulmonary Aspergilloma, Vulvectomy, and Lung Transplant.
Summary: The purpose of this study is to evaluate the safety and tolerability of a single intravenous dose of MP101 administered in addition to standard antibiotic therapy in adult patients with acute Pseudomonas aeruginosa pneumonia. The study will also assess the pharmacokinetic and pharmacodynamic characteristics of MP101 and its antibacterial activity, including changes in P. aeruginosa burden in sputu...
Objectives: The primary objective of this study is to investigate the local tolerability of isoniazid inhalation by wet nebulization at single ascending dosages. Secondary objective is systemic pharmacokinetics of inhaled isoniazid compared to intravenous dose administration. Study design: single-center, single ascending dose tolerability study. Participants will receive one intravenous dose of 300 mg INH and...


